SEC Form 4 · accession 0001209191-17-056359
BELDEN INC. · BDC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John S Stroup
Officer — Chairman, President and CEO · Director
Period of report
Oct 6, 2017
Accepted (ET)
Oct 10, 2017 · 8:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000913142
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 6, 2017 | S | 10,000 | $84.70 | D | 21,713 | D | |
| Common Stock | Oct 6, 2017 | M | 34,147 | $50.01 | A | 55,860 | D | |
| Common StockF3 | Oct 6, 2017 | D | 26,920 | $84.28 | D | 28,940 | D | |
| Common StockF4 | Oct 9, 2017 | S | 7,227 | $84.8212 | D | 21,713 | D | |
| Common Stock | holding | — | — | — | 4,063 | I | By Irrevocable Trust for Children | |
| Common Stock | holding | — | — | — | 86,555 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF5 | $50.01 | Oct 6, 2017 | M | 34,147 | D | — | Mar 4, 2023 | Common Stock | 34,147 | 0 | D |
Explanation of responses
- F1The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Stroup on August 18, 2016.
- F2The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Stroup on August 18, 2016.
- F3This represents the difference between the number of SARs exercised (34,147) and the number of shares issued as a result of the exercise (7,227). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($84.28) and the exercise price ($50.01). Additional shares are then withheld to satisfy the Company's tax withholding obligations.
- F4This price represents the average sale price for multiple transactions on this line. The prices of the transactions reported on this line ranged from $84.41 to $85.57. Upon request by the SEC staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares and prices at which transactions were effected.
- F5From the original grant of 74,147 SARs, 24,716 became exercisable on March 4, 2014, 24,716 became exercisable on March 4, 2015 and 24,715 became exercisable on March 4, 2016.